Asahi Kasei Corp. has said it will acquire German pharmaceutical developer Aicuris Anti-Infective Cures AG for some 780 million euros. The major Japanese chemical maker will obtain all outstanding ...

Asahi Kasei stock: recent performance snapshot Asahi Kasei (TSE:3407) has drawn fresh attention after a strong run over the past month and past 3 months, with the share price also posting a solid ...

Asahi Kasei has unveiled plans to acquire Aicuris in a deal worth 780 million euros ($920 million), marking the latest in a ...

The data included names and phone numbers of client companies' executives and employees as well as names and addresses of current and past Asahi Group staff.

Advancing Expansion in Severe Infectious Disease and Leveraging Existing Global Infrastructure to Drive Long-Term ...

Wuppertal, Germany, February 26, 2026 - Aicuris Anti-infective Cures AG (“Aicuris”) today announced that it has entered into a definitive agreement under which Asahi Kasei, through its wholly owned U.

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty pharmaceutical platform.

Japanese beverage maker Asahi says deliveries of its products have returned to normal after the disruptions caused by last year's cyberattack.

Japanese beverage firm Asahi Group Holdings Ltd. said Wednesday that a cyberattack it suffered last September led to the leak ...